LY6D and clear cell renal carcinoma: LY6D: Recent clinical outcome data added and published by Km plotter web tool show that increased RNA expression of LY6D is associated with poor prognosis in renal clear cell carcinoma and pancreatic ductal adenocarcinoma [Figure 1, (38)].